Orexigen Therapeutics, Inc.
OREX
OREX was delisted on the 3rd of April, 2018.
1 hedge funds and large institutions have $0 invested in Orexigen Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
75% less funds holding
Funds holding: 4 → 1 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less capital invested
Capital invested by funds: $1K → $0 (-$1K)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
California Public Employees Retirement System
Sacramento,
California
| – | -$1K | -28,420 | Closed |
|
OREX Hedge Fund Activity: Q3 2018 in Review
1 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Orexigen Therapeutics, Inc. (OREX) for Q3 2018, worth a combined $0 — down 100% from $1K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of OREX and 1 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was California Public Employees Retirement System, exiting entirely with an estimated $1K sold.
- 1 institutional investor held Orexigen Therapeutics, Inc. (OREX) as of Q3 2018, down from 4 in Q2 2018.
- Funds reported $0 of Orexigen Therapeutics, Inc. stock for Q3 2018, down 100% quarter-over-quarter.
- 1 fund opened new Orexigen Therapeutics, Inc. positions in Q3 2018 and 4 closed out, a net change of -3 holders.
- The largest Orexigen Therapeutics, Inc. seller in Q3 2018 was California Public Employees Retirement System, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2018.